Katrin Mittmann

No ORCID on file · 8 papers in corpus · active 2005-2015

Study types

  • article 8

Condition tags

  • die_deep_infiltrating 1
article 2015
Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days
·doi:10.3109/09513590.2015.1024220

BACKGROUND: Concern and controversy characterize nowadays the use of hormone therapy for management of patients with menopausal complaints. This observational non-interventional study examined the use of a marketed oral formulation containi…

article 2011
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy
·doi:10.1016/j.contraception.2011.01.002
article 2010
Effects of Combined Oral Contraceptive Ethinylestradiol (30 μg) and Dienogest (2 mg) on Carbohydrate Metabolism During 1 Year of Conventional or Extended-Cycle Use
·doi:10.1055/s-0030-1248263

The effects of extended regimens of combined oral contraceptives (COCs) on carbohydrate metabolism are largely unknown. The present study compared the effects of a COC containing 30 microg ethinylestradiol and 2 mg dienogest (EE/DNG) in con…

article 2009
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use
·doi:10.1016/j.contraception.2009.07.011
article 2008
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use
·doi:10.1016/j.contraception.2008.02.005
article 2008
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters
·doi:10.1016/j.contraception.2008.06.015
article 2006
Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest
·doi:10.1016/j.fertnstert.2005.11.052
article 2005
Fertilität nach Absetzten eines oralen Kontrazeptivums mit 30µg Ethinylestradiol und 2mg Dienogest
·doi:10.1055/s-2005-870731

Fragestellung: Retrospektiven Untersuchungen haben gezeigt, dass die Fertilität nach dem Absetzen eines oralen Kontrazeptivums (OC) für die Dauer von bis zu 2 Jahren negativ beeinflusst werden kann. Bei repräsentativen Umfragen nahmen in Dr…